Multicystic Interstitial Lung Disease Due to a Novel Biallelic C-C Chemokine Receptor Type 2 Variant.

由新型双等位基因 CC 趋化因子受体 2 型变体引起的多囊性间质性肺病

阅读:5
作者:Herkner Moritz, Rapp Christina, Graeber Simon Y, Marx Charlotte, Rambuscheck Carlotta, Reu-Hofer Simone, Emiralioglu Nagehan, Kiper Nural, Gilea Alexandru I, Notaroberto Ilenia, Baruffini Enrico, Temmesfeld-Wollbrück Bettina, Klein Christoph, Wen Han, Stahl Mirjam, Griese Matthias, Gothe Florian
OBJECTIVE: We are presenting two individuals with biallelic C-C chemokine receptor type 2 (CCR2) deficiency carrying the novel c.644C>T p.L215P variant, who presented with chronic respiratory symptoms during infancy and developed multiple diffuse cystic lesions during childhood. METHODS: The patients were diagnosed by means of whole exome sequencing and functional validation of the variant was performed in primary patient cells. RESULTS: While size and extent of the cysts were stable over years, progressive lung function decline was noted in adolescence and adulthood respectively. The CCR2 p.L215P variant was found to be loss-of-expression and patient monocytes displayed a migration defect upon stimulation with the CCR2 ligand C-C motif ligand 2 (CCL2). CONCLUSION: With a follow-up of up to 25 years, this report expands our understanding of lung disease in CCR2 deficiency and offers another monogenic cause of cystic lung disease. Early genetic diagnosis of affected individuals might allow potentially curative treatment by haematopoietic stem cell transplantation.

特别声明

1、本文转载旨在传播信息,不代表本网站观点,亦不对其内容的真实性承担责任。

2、其他媒体、网站或个人若从本网站转载使用,必须保留本网站注明的“来源”,并自行承担包括版权在内的相关法律责任。

3、如作者不希望本文被转载,或需洽谈转载稿费等事宜,请及时与本网站联系。

4、此外,如需投稿,也可通过邮箱info@biocloudy.com与我们取得联系。